Overview
The customer is a US based Biopharmaceutical company involved in the discovery, development, and commercialized therapies for the treatment of rare cardiovascular diseases.
Challenges
- Need for evaluating the safety and efficacy of an orally administered small molecule designed to prevent or reverse Hypertrophic Cardio-Myopathy (HCM) progression
- The trial needs to demonstrate quick advancement to the sponsor
- Client needs the necessary Expert resources and operational knowledge to play out the trial and help to push them to the advance level
Outcomes
Real time insights into Trial operations
Stronger Financial Management
Efficient Regulatory process
Increased Staff efficiency and management